Identification of amino acid determinants in CYP4B1 for optimal catalytic processing of 4-ipomeanol

Constanze Wiek, Eva M. Schmidt, Katharina Roellecke, Marcel Freund, Mariko Nakano, Edward J. Kelly, Wolfgang Kaisers, Vladimir Yarov-Yarovoy, Christof M. Kramm, Allan E. Rettie, Helmut Hanenberg

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Mammalian CYP4B1 enzymes are cytochrome P450 mono-oxygenases that are responsible for the bioactivation of several exogenous pro-toxins including 4-ipomeanol (4-IPO). In contrast with the orthologous rabbit enzyme, we show here that native human CYP4B1 with a serine residue at position 427 is unable to bioactivate 4-IPO and does not cause cytotoxicity in HepG2 cells and primary human T-cells that overexpress these enzymes. We also demonstrate that a proline residue in the meander region at position 427 in human CYP4B1 and 422 in rabbit CYP4B1 is important for protein stability and rescues the 4-IPO bioactivation of the human enzyme, but is not essential for the catalytic activity of the rabbit CYP4B1 protein. Systematic substitution of native and p.S427P human CYP4B1 with peptide regions from the highly active rabbit enzyme reveals that 18 amino acids in the wild-type rabbit CYP4B1 protein are key for conferring high 4-IPO metabolizing activity. Introduction of 12 of the 18 amino acids that are also present at corresponding positions in other human CYP4 family members into the p.S427P human CYP4B1 protein results in a mutant human enzyme (P + 12) that is as stable and as active as the rabbit wild-type CYP4B1 protein. These 12 mutations cluster in the predicted B-C loop through F-helix regions and reveal new amino acid regions important to P450 enzyme stability. Finally, by minimally re-engineering the human CYP4B1 enzyme for efficient activation of 4-IPO, we have developed a novel human suicide gene system that is a candidate for adoptive cellular therapies in humans.

Original languageEnglish (US)
Pages (from-to)103-114
Number of pages12
JournalBiochemical Journal
Volume465
DOIs
StatePublished - Jan 1 2015

Fingerprint

Amino Acids
Processing
Rabbits
Enzymes
Proteins
Cytochrome P-450 Enzyme System
4-ipomeanol
cytochrome P-450 CYP4B1
Enzyme Stability
Oxygenases
Enzyme Activation
T-cells
Human Engineering
Protein Stability
Hep G2 Cells
Cytotoxicity
Population Groups
Proline
Suicide
Serine

Keywords

  • 4-ipomeanol
  • Cytochrome P450 4B1 (CYP4B1)
  • Suicide gene system

ASJC Scopus subject areas

  • Biochemistry
  • Cell Biology
  • Molecular Biology

Cite this

Wiek, C., Schmidt, E. M., Roellecke, K., Freund, M., Nakano, M., Kelly, E. J., ... Hanenberg, H. (2015). Identification of amino acid determinants in CYP4B1 for optimal catalytic processing of 4-ipomeanol. Biochemical Journal, 465, 103-114. https://doi.org/10.1042/BJ20140813

Identification of amino acid determinants in CYP4B1 for optimal catalytic processing of 4-ipomeanol. / Wiek, Constanze; Schmidt, Eva M.; Roellecke, Katharina; Freund, Marcel; Nakano, Mariko; Kelly, Edward J.; Kaisers, Wolfgang; Yarov-Yarovoy, Vladimir; Kramm, Christof M.; Rettie, Allan E.; Hanenberg, Helmut.

In: Biochemical Journal, Vol. 465, 01.01.2015, p. 103-114.

Research output: Contribution to journalArticle

Wiek, C, Schmidt, EM, Roellecke, K, Freund, M, Nakano, M, Kelly, EJ, Kaisers, W, Yarov-Yarovoy, V, Kramm, CM, Rettie, AE & Hanenberg, H 2015, 'Identification of amino acid determinants in CYP4B1 for optimal catalytic processing of 4-ipomeanol', Biochemical Journal, vol. 465, pp. 103-114. https://doi.org/10.1042/BJ20140813
Wiek, Constanze ; Schmidt, Eva M. ; Roellecke, Katharina ; Freund, Marcel ; Nakano, Mariko ; Kelly, Edward J. ; Kaisers, Wolfgang ; Yarov-Yarovoy, Vladimir ; Kramm, Christof M. ; Rettie, Allan E. ; Hanenberg, Helmut. / Identification of amino acid determinants in CYP4B1 for optimal catalytic processing of 4-ipomeanol. In: Biochemical Journal. 2015 ; Vol. 465. pp. 103-114.
@article{920255ef1eba4ac4b5d35ead542e4832,
title = "Identification of amino acid determinants in CYP4B1 for optimal catalytic processing of 4-ipomeanol",
abstract = "Mammalian CYP4B1 enzymes are cytochrome P450 mono-oxygenases that are responsible for the bioactivation of several exogenous pro-toxins including 4-ipomeanol (4-IPO). In contrast with the orthologous rabbit enzyme, we show here that native human CYP4B1 with a serine residue at position 427 is unable to bioactivate 4-IPO and does not cause cytotoxicity in HepG2 cells and primary human T-cells that overexpress these enzymes. We also demonstrate that a proline residue in the meander region at position 427 in human CYP4B1 and 422 in rabbit CYP4B1 is important for protein stability and rescues the 4-IPO bioactivation of the human enzyme, but is not essential for the catalytic activity of the rabbit CYP4B1 protein. Systematic substitution of native and p.S427P human CYP4B1 with peptide regions from the highly active rabbit enzyme reveals that 18 amino acids in the wild-type rabbit CYP4B1 protein are key for conferring high 4-IPO metabolizing activity. Introduction of 12 of the 18 amino acids that are also present at corresponding positions in other human CYP4 family members into the p.S427P human CYP4B1 protein results in a mutant human enzyme (P + 12) that is as stable and as active as the rabbit wild-type CYP4B1 protein. These 12 mutations cluster in the predicted B-C loop through F-helix regions and reveal new amino acid regions important to P450 enzyme stability. Finally, by minimally re-engineering the human CYP4B1 enzyme for efficient activation of 4-IPO, we have developed a novel human suicide gene system that is a candidate for adoptive cellular therapies in humans.",
keywords = "4-ipomeanol, Cytochrome P450 4B1 (CYP4B1), Suicide gene system",
author = "Constanze Wiek and Schmidt, {Eva M.} and Katharina Roellecke and Marcel Freund and Mariko Nakano and Kelly, {Edward J.} and Wolfgang Kaisers and Vladimir Yarov-Yarovoy and Kramm, {Christof M.} and Rettie, {Allan E.} and Helmut Hanenberg",
year = "2015",
month = "1",
day = "1",
doi = "10.1042/BJ20140813",
language = "English (US)",
volume = "465",
pages = "103--114",
journal = "Biochemical Journal",
issn = "0264-6021",
publisher = "Portland Press Ltd.",

}

TY - JOUR

T1 - Identification of amino acid determinants in CYP4B1 for optimal catalytic processing of 4-ipomeanol

AU - Wiek, Constanze

AU - Schmidt, Eva M.

AU - Roellecke, Katharina

AU - Freund, Marcel

AU - Nakano, Mariko

AU - Kelly, Edward J.

AU - Kaisers, Wolfgang

AU - Yarov-Yarovoy, Vladimir

AU - Kramm, Christof M.

AU - Rettie, Allan E.

AU - Hanenberg, Helmut

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Mammalian CYP4B1 enzymes are cytochrome P450 mono-oxygenases that are responsible for the bioactivation of several exogenous pro-toxins including 4-ipomeanol (4-IPO). In contrast with the orthologous rabbit enzyme, we show here that native human CYP4B1 with a serine residue at position 427 is unable to bioactivate 4-IPO and does not cause cytotoxicity in HepG2 cells and primary human T-cells that overexpress these enzymes. We also demonstrate that a proline residue in the meander region at position 427 in human CYP4B1 and 422 in rabbit CYP4B1 is important for protein stability and rescues the 4-IPO bioactivation of the human enzyme, but is not essential for the catalytic activity of the rabbit CYP4B1 protein. Systematic substitution of native and p.S427P human CYP4B1 with peptide regions from the highly active rabbit enzyme reveals that 18 amino acids in the wild-type rabbit CYP4B1 protein are key for conferring high 4-IPO metabolizing activity. Introduction of 12 of the 18 amino acids that are also present at corresponding positions in other human CYP4 family members into the p.S427P human CYP4B1 protein results in a mutant human enzyme (P + 12) that is as stable and as active as the rabbit wild-type CYP4B1 protein. These 12 mutations cluster in the predicted B-C loop through F-helix regions and reveal new amino acid regions important to P450 enzyme stability. Finally, by minimally re-engineering the human CYP4B1 enzyme for efficient activation of 4-IPO, we have developed a novel human suicide gene system that is a candidate for adoptive cellular therapies in humans.

AB - Mammalian CYP4B1 enzymes are cytochrome P450 mono-oxygenases that are responsible for the bioactivation of several exogenous pro-toxins including 4-ipomeanol (4-IPO). In contrast with the orthologous rabbit enzyme, we show here that native human CYP4B1 with a serine residue at position 427 is unable to bioactivate 4-IPO and does not cause cytotoxicity in HepG2 cells and primary human T-cells that overexpress these enzymes. We also demonstrate that a proline residue in the meander region at position 427 in human CYP4B1 and 422 in rabbit CYP4B1 is important for protein stability and rescues the 4-IPO bioactivation of the human enzyme, but is not essential for the catalytic activity of the rabbit CYP4B1 protein. Systematic substitution of native and p.S427P human CYP4B1 with peptide regions from the highly active rabbit enzyme reveals that 18 amino acids in the wild-type rabbit CYP4B1 protein are key for conferring high 4-IPO metabolizing activity. Introduction of 12 of the 18 amino acids that are also present at corresponding positions in other human CYP4 family members into the p.S427P human CYP4B1 protein results in a mutant human enzyme (P + 12) that is as stable and as active as the rabbit wild-type CYP4B1 protein. These 12 mutations cluster in the predicted B-C loop through F-helix regions and reveal new amino acid regions important to P450 enzyme stability. Finally, by minimally re-engineering the human CYP4B1 enzyme for efficient activation of 4-IPO, we have developed a novel human suicide gene system that is a candidate for adoptive cellular therapies in humans.

KW - 4-ipomeanol

KW - Cytochrome P450 4B1 (CYP4B1)

KW - Suicide gene system

UR - http://www.scopus.com/inward/record.url?scp=84918540338&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84918540338&partnerID=8YFLogxK

U2 - 10.1042/BJ20140813

DO - 10.1042/BJ20140813

M3 - Article

C2 - 25247810

AN - SCOPUS:84918540338

VL - 465

SP - 103

EP - 114

JO - Biochemical Journal

JF - Biochemical Journal

SN - 0264-6021

ER -